Abbott Tries To Nix Amended HIV Drug Price Suits

Law360, New York (September 11, 2009, 3:26 PM EDT) -- Abbott Laboratories has asked a judge to throw out four recently amended complaints filed by pharmacies, wholesale direct drug purchasers and rival drug manufacturers alleging Abbott illegally jacked up the prices of its market-dominating HIV drugs, calling the complaints “a vain attempt to plead around” recent antitrust case law.

Rite Aid Corp., Meijer Inc., Safeway Inc., GlaxoSmithKline PLC and the other plaintiffs have not alleged any form of exclusionary conduct, the central element in any monopolization claim, according to Abbott's motion, filed Thursday in the U.S....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.